Treatment of Febrile Neutropenia Is Expensive: Prevention Is the Answer

Publisher： Karger

E-ISSN： 2296-5262|34|5|226-228

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.5, 2011-04, pp. : 226-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ceftriaxone in the Treatment of Solid Tumour Patients with Febrile Neutropenia

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

G-CSF in the Prevention of Febrile Neutropenia in Chemotherapy in Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

By Cherif Honar   Björkholm Magnus   Engervall Per   Johansson Peter   Ljungman Per   Hast Robert   Kalin Mats  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 8, 2004-08 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Cefepime and Ceftazidime in Combination with Amikacin in the Empirical Treatment of High-risk Patients with Febrile Neutropenia: A Prospective, Randomized, Multicenter Study

By Erman Mustafa   Akova Murat   Akan Hamdi   Korten Volkan   Ferhanoğlu Burhan   Köksal Iftihar   Çetinkaya Yeşim   Uzun Ömrüm   Ünal Serhat  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite

MONITOR‐GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy‐induced/febrile neutropenia prophylaxis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite